申请人:——
公开号:US20040038979A1
公开(公告)日:2004-02-26
Compounds of the formula I, in which Het is an unsubstituted or R6-and/or R7-sustituted pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrimidinyl, pyrazinyl or pyridazinyl radical, or an unsubstituted or R6-and/or R7-substituted fused bi-or tricyclic ring system comprising at least one aromatic ring and up to 4 heteroatoms—selected from the group consisting of O(oxygen), S(sulphur) or N(nitrogen)—which is bonded to the phenanthridinyl radical via one of the rings comprising one or more rheteroatoms, areactive PDE4 inhibitors.
1
公式I的化合物中,Het是未取代或R6-和/或R7-取代的吡咯基、呋喃基、噻吩基、吡唑基、咪唑基、噁唑基、异噁唑基、噻唑基、异噻唑基、噻二唑基、嘧啶基、吡嗪基或吡啶基基团,或未取代或R6-和/或R7-取代的融合的双环或三环芳香环系统,包括至少一个芳香环和最多4个来自O(氧)、S(硫)或N(氮)的杂原子中的一个的杂原子,通过其中一个含有一个或多个杂原子的环与苯并喹啉基结合,是活性的PDE4抑制剂。